المؤلفون: Makady A; The National Healthcare Institute, Diemen, The Netherlands; Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands. Electronic address: amakady@zinl.nl., van Acker S; Vrije Universiteit, Amsterdam, The Netherlands., Nijmeijer H; Radboud University Medical Centre, Nijmegen, The Netherlands., de Boer A; Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands., Hillege H; Department of Epidemiology, University Medical Centre Groningen, Groningen, The Netherlands., Klungel O; Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands., Goettsch W; The National Healthcare Institute, Diemen, The Netherlands; Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.

المصدر: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2019 Apr; Vol. 22 (4), pp. 399-407.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

مواضيع طبية MeSH: Drug Costs*/legislation & jurisprudence , Health Expenditures*/legislation & jurisprudence , Hospital Costs*/legislation & jurisprudence , Stakeholder Participation*, Drug Approval/*economics , Financial Management, Hospital/*economics , Technology Assessment, Biomedical/*economics, Budgets ; Drug Approval/legislation & jurisprudence ; Financial Management, Hospital/legislation & jurisprudence ; Health Policy/economics ; Humans ; Interviews as Topic ; Netherlands ; Policy Making ; Program Evaluation ; Technology Assessment, Biomedical/legislation & jurisprudence

المؤلفون: Makady A; National Healthcare Institute (ZIN), Diemen, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands. Electronic address: amakady@zinl.nl., van Veelen A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands., de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands., Hillege H; Department of Epidemiology, University Medical Centre Groningen, Groningen, the Netherlands., Klungel OH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands., Goettsch W; National Healthcare Institute (ZIN), Diemen, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands.

المصدر: Health policy (Amsterdam, Netherlands) [Health Policy] 2019 Mar; Vol. 123 (3), pp. 267-274. Date of Electronic Publication: 2018 Sep 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8409431 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6054 (Electronic) Linking ISSN: 01688510 NLM ISO Abbreviation: Health Policy

مواضيع طبية MeSH: Cost-Benefit Analysis* , Drug Costs* , Hospital Costs*, Drug Approval/*economics , Technology Assessment, Biomedical/*economics, Decision Making ; Drug Approval/methods ; Health Policy/economics ; Humans ; Netherlands ; Program Evaluation ; Reimbursement Mechanisms ; Retrospective Studies ; Technology Assessment, Biomedical/methods

المؤلفون: Eichler HG; European Medicines Agency (EMA), London, UK., Baird LG, Barker R, Bloechl-Daum B, Børlum-Kristensen F, Brown J, Chua R, Del Signore S, Dugan U, Ferguson J, Garner S, Goettsch W, Haigh J, Honig P, Hoos A, Huckle P, Kondo T, Le Cam Y, Leufkens H, Lim R, Longson C, Lumpkin M, Maraganore J, O'Rourke B, Oye K, Pezalla E, Pignatti F, Raine J, Rasi G, Salmonson T, Samaha D, Schneeweiss S, Siviero PD, Skinner M, Teagarden JR, Tominaga T, Trusheim MR, Tunis S, Unger TF, Vamvakas S, Hirsch G

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2015 Mar; Vol. 97 (3), pp. 234-46. Date of Electronic Publication: 2015 Feb 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Licensure*, Drug Approval/*legislation & jurisprudence , Drug Approval/*methods , Drug Discovery/*legislation & jurisprudence, Humans